Amicus Therapeutics (FOLD) Reports a Narrower Q3 Loss; Comments on FY08
Tweet Send to a Friend
Amicus Therapeutics, Inc. (Nasdaq: FOLD) reports Q3 loss of $0.29, 18 cents better than ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
